Syquant Capital SAS’s Meridian Bioscience Inc VIVO Stock Holding History

Syquant Capital SAS’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-134,804	Closed	-$4.48M	–	20
2022 Q4	$4.48M	Buy	+134,804	New	+$4.34M	11.01%	4

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Syquant Capital SAS's VIVO Position: Q1 2023 in Review

Syquant Capital SAS sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 134,804 shares — an estimated $4.48M sold.

Syquant Capital SAS first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $4.48M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Syquant Capital SAS reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Syquant Capital SAS sold 134,804 Meridian Bioscience Inc shares in Q1 2023, an estimated $4.48M.
Syquant Capital SAS first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Syquant Capital SAS's Meridian Bioscience Inc position peaked at $4.48M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Syquant Capital SAS's 13F filing for Q1 2023, filed 12 Apr 2023.